| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-01328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C10M105-56 |
| filingDate |
2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f662abbde6a0fc990d20e85c39e34b64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b1f8a92aebcf85bc9d49aa90e81d880 |
| publicationDate |
2019-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019126364-A2 |
| titleOfInvention |
Compositions and methods related to nicotine addiction and cessation |
| abstract |
The present invention provides nicotine-degrading fusion enzymes that are comprised of a N-terminally truncated nicotine-degrading enzyme (e.g., NicA2) and a fusion partner (e.g., an albumin binding moiety). The invention also provides therapeutic methods of using the fusion enzymes for promoting nicotine cessation, treating nicotine addiction or nicotine poisoning, and prevent relapse. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597916-B2 |
| priorityDate |
2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |